Exchange: NASDAQ·Updated 02:54 PM EDT
GDTC logo

GDTC CYTOMED THERAPEUTICS LIMITED

$0.935
$0.065
(6.50%)
Today
Mkt Cap$11.83M
Vol15,557.00

About GDTC

CytoMed Therapeutics Ltd. is a biopharmaceutical company, which engages in the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy, and undertaking the research and development of immune cell and stem cell-based therapy. It operates through the Malaysia and Singapore geographical segments. The company was founded by Chee Kong Choo on March 9, 2018 and is headquartered in Singapore.
58

Bullish Sentiment

How do you feel about GDTC?

Advertisement|Remove ads.